Perioperative anesthetic management in pediatric heart transplantation: a single-center descriptive study involving 27 patients
Frontiers in Pediatrics · 18.06.2026 · 14
DOI: 10.3389/fped.2026.1842135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 18.06.2026. Verfasst von Ya-Fei Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Seventh Medical Center to Chinese PLA General Hospital, Beijing, China. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Orthotopic heart transplantation is the standard treatment for pediatric end-stage heart disease. Due to the wide age range and high physiological heterogeneity among pediatric recipients, perioperative anesthesia management is particularly complex. Literature describing real-world perioperative practices for high-risk populations remains limited.
Objective
This descriptive study aims to summarize the perioperative anesthesia management strategies and short-term clinical outcomes for pediatric heart transplant recipients at a single center.
Methods
This retrospective descriptive study enrolled 27 pediatric patients who underwent orthotopic heart transplantation at a single center from May 2022 to October 2025. Data on baseline characteristics, intraoperative variables, complications, and outcomes were collected. No control group was established, and no causal inference was performed. Results he cohort included 27 patients (13 male, 14 female), aged 6 months to 16 years (weight 7.0–95.0 kg). Dilated cardiomyopathy was the most common diagnosis (20/27, 74.1%). All patients were NYHA class III–IV; median LVEF was 28.5%. Preoperative ECMO support was used in 15 patients (55.6%). No major cardiovascular events occurred during induction or pre-CPB. Mean CPB time was 183.3 ± 55.6 min; mean cold ischemia time was 249.5 ± 101.1 min. Mean postoperative mechanical ventilation was 7.7 ± 9.5 days. Postoperative ECMO was required in 11 patients (40.7%). At follow-up, 23 patients were alive and 4 died (survival 85.2%). Major complications included hypoxic-ischemic encephalopathy ( n = 4), AKI requiring CRRT ( n = 5), and peripheral nerve injury ( n = 2).
Conclusion
Among the pediatric heart transplant recipients with severe conditions in this cohort (including a high proportion of ECMO bridged cases), the perioperative anesthesia management strategy implemented included low-dose staged induction, invasive monitoring, and multidisciplinary collaboration. Pulmonary hypertension, primary graft dysfunction, and multi-organ complications were commonly observed in this cohort. This study is descriptive and observational; causal relationships cannot be inferred, and the findings require further validation in larger sample sizes or multicenter studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, The Seventh Medical Center to Chinese PLA General Hospital, Beijing, China.
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Zitieren
APA
Cheng, Y. F., Meng, C. L., Wang, Y. R., Chen, L., Ma, Y. Q., Guo, W. Z., & Guo, H. (2026). Perioperative anesthetic management in pediatric heart transplantation: a single-center descriptive study involving 27 patients. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1842135
Vancouver
Cheng YF, Meng CL, Wang YR, Chen L, Ma YQ, Guo WZ, et al. Perioperative anesthetic management in pediatric heart transplantation: a single-center descriptive study involving 27 patients. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1842135
BibTeX
@article{Cheng2026,
author = {Cheng, Ya-Fei and Meng, Cong-Li and Wang, Yi-Ru and Chen, Lin and Ma, Ya-Qun and Guo, Wen-Zhi and Guo, Hang},
title = {Perioperative anesthetic management in pediatric heart transplantation: a single-center descriptive study involving 27 patients},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.1842135}
}
EUVIMED